title: Lamellar macular hole formation in a patient with diabetic CME treated by intravitreal bevacizumab injections.
abstract: A 49-year-old woman with a diagnosis of diabetic cystoid macular edema in both eyes presented with the appearance of a macular hole in the left eye 1 month after intravitreal bevacizumab injection. Optical coherence tomography demonstrated a lamellar macular hole in the left eye. Although vitreomacular traction and epiretinal membrane are the possible underlying causes for the development of lamellar macular hole formation in eyes with cystoid macular edema, in this case previous optical coherence tomography scans revealed the complete separation of the posterior hyaloid membrane and the absence of an epiretinal membrane. The exact mechanism involved in the progression of cystoid macular edema to lamellar macular hole and the contribution of the intravitreal bevacizumab injections to this transformation remain unclear.
authors.affiliation: Department of Ophthalmology, Gulhane Military Medical Academy and School of Medicine, Ankara, Turkey. erdurman@yahoo.com
authors.forename: F Cuneyt
authors.initials: FC
authors.lastname: Erdurman
authors.forename: Alfrida
authors.initials: A
authors.lastname: Pellumbi
authors.forename: A Hakan
authors.initials: AH
authors.lastname: Durukan
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000068258:Bevacizumab; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections / Q000009:adverse effects; D008269:Macular Edema / Q000188:drug therapy*; D008875:Middle Aged; D012167:Retinal Perforations / Q000209:etiology*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab